Speeding up the early stages of drug discovery will improve profitability and get new therapies on the market faster. This is now possible with waveRAPID®, the new way of measuring kinetics. In a traditional ligand binding assay, the analyte is titrated at increasing concentrations, with the same injection duration.
Speeding up the early stages of drug discovery will improve profitability and get new therapies on the market faster. This is now possible with waveRAPID®, the new way of measuring kinetics. In a traditional ligand binding assay, the analyte is titrated at increasing concentrations, with the same injection duration.
